FABP1 and gastric cancer: Takeaki Hashimoto et al. reported that the expression level of FABP1 was not associated with GC prognosis (Hashimoto et al., 2004); while another study revealed that it was a reliable prognostic indicator of GC (Satoh et al., 2012).